Evidence map›Paper›PMID 32370945›Full record

ArticleMetabolism: clinical and experimental2020

Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle.

Patrick R Davis, Spencer G Miller, Nicolas A Verhoeven, Joshua S Morgan, David A Tulis, Carol A Witczak, Jeffrey J Brault

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. What can ATP content tell us about Barth syndrome muscle phenotypes?Journal of translational genetics and genomics · 2025
    Article
  5. Role of AMP deaminase in diabetic cardiomyopathy.Molecular and cellular biochemistry · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Patrick R DavisDepartment of Kinesiology, East Carolina University, United States of America.
Spencer G MillerDepartment of Kinesiology, East Carolina University, United States of America.
Nicolas A VerhoevenDepartment of Kinesiology, East Carolina University, United States of America.
Joshua S MorganDepartment of Physiology, Brody School of Medicine, East Carolina University, United States of America.
David A TulisDepartment of Physiology, Brody School of Medicine, East Carolina University, United States of America.
Carol A WitczakDepartment of Kinesiology, East Carolina University, United States of America; Department of Physiology, Brody School of Medicine, East Carolina University, United States of America; Department of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, United States of America.
Jeffrey J BraultDepartment of Kinesiology, East Carolina University, United States of America; Department of Physiology, Brody School of Medicine, East Carolina University, United States of America; Department of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, United States of America. Electronic address: jebrault@iu.edu.
East Carolina University · US

Funding

Calmodulin Kinases and Control of Skeletal Muscle Glucose MetabolismR01DK103562 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI WITCZAK, CAROL ANN · 2015 to 2019
$1.7M
CELLULAR ENERGETICS AS A REGULATOR OF MUSCLE MASS AND MITOCHONDRIAL CONTENT DURING MUSCLE ATROPHYR01AR070200 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI BRAULT, JEFFREY J · 2017 to 2021
$1.6M
Acid-sensing GPCRs in vascular inflammation and growthR15HL135699 · NHLBI · EAST CAROLINA UNIVERSITY · PI TULIS, DAVID A · 2017 to 2017
$443k
NHLBI NIH HHS R15 HL135699NIAMS NIH HHS R01 AR070200NIDDK NIH HHS R01 DK103562
6 · The paper itself

Abstract

backgroundProtein degradation is an energy-dependent process, requiring ATP at multiple steps. However, reports conflict as to the relationship between intracellular energetics and the rate of proteasome-mediated protein degradation.

methodsTo determine whether the concentration of the adenine nucleotide pool (ATP + ADP + AMP) affects protein degradation in muscle cells, we overexpressed an AMP degrading enzyme, AMP deaminase 3 (AMPD3), via adenovirus in C2C12 myotubes.

resultsOverexpression of AMPD3 resulted in a dose- and time-dependent reduction of total adenine nucleotides (ATP, ADP and AMP) without increasing the ADP/ATP or AMP/ATP ratios. In agreement, the reduction of total adenine nucleotide concentration did not result in increased Thr172 phosphorylation of AMP-activated protein kinase (AMPK), a common indicator of intracellular energetic state. Furthermore, LC3 protein accumulation and ULK1 (Ser 555) phosphorylation were not induced. However, overall protein degradation and ubiquitin-dependent proteolysis were slowed by overexpression of AMPD3, despite unchanged content of several proteasome subunit proteins and proteasome activity in vitro under standard conditions.

conclusionsAltogether, these findings indicate that a physiologically relevant decrease in ATP content, without a concomitant increase in ADP or AMP, is sufficient to decrease the rate of protein degradation and activity of the ubiquitin-proteasome system in muscle cells. This suggests that adenine nucleotide degrading enzymes, such as AMPD3, may be a viable target to control muscle protein degradation and perhaps muscle mass.

Indexed as

Adenosine DiphosphateAdenosine MonophosphateAdenosine TriphosphateAMP-Activated Protein KinasesAMP DeaminaseAnimalsCells, CulturedMiceMuscle Fibers, SkeletalMuscle, SkeletalPhosphorylationProteasome Endopeptidase ComplexProtein SubunitsProteolysisUbiquitinAdenosine DiphosphateAdenosine MonophosphateAdenosine TriphosphateAMP-Activated Protein KinasesAMP DeaminaseProteasome Endopeptidase ComplexProtein SubunitsUbiquitinAdenine nucleotidesC2C12 myoblastsEnergeticsProtein degradationUbiquitin-proteasome system

Identifiers

PMID32370945
PMCPMC7319876
OpenAlexW3023662423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.